NY0116
NY0116 is a neuromedin U receptor 2 (NMUR2) agonist with EC50 values of 27.76 μM for hNMUR1 and 13.61 μM for hNMUR2. NY0116 decreases cAMP while stimulating calcium signaling in stably expressing NMUR2 HEK293 cells.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- CAS No.: 1003000-59-6
- Formule: C22H23N3O
- Masse moléculaire:345.44
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Activité biologique
Description
In Vitro
NY0116 has potent dose-dependent inhibition of cAMP (EC50 of 1.69 nM) in HEK293 cells stably expressing hNMUR2. NY0116 also stimulates calcium signaling in cells[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. .
In Vivo
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Male diet induced obese (DIO) C57BL/6J mice age 18 weeks and 8 age[1]
-
Dosage:3, 10, 30 mg/kg
-
Administration:Subcutaneous injection; for 14 days
-
Result:Significantly decreased bodyweight compared to vehicle, whereas mice were maintained on a high-fat diet.
Chemical Information
-
CAS No. 1003000-59-6
-
Masse moléculaire 345.44
-
Formule C22H23N3O
-
SMILES
NC(NCCOC(C1=CC=CC=C1)(C2=CC=CC=C2)C3=CC=CC=C3)=N
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation
Références
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)